Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial

CompletedOBSERVATIONAL
Timeline

Start Date

June 30, 2005

Conditions
Hepatitis B
Trial Locations (27)

Unknown

Pusan National University Hospital, Ami-dong, Seo-gu

Kosin Medical Center, Amnam-dong, Seo-gu

Yeungnam University Medical Center, Daemyoung-dong, Nam-gu

Keimyumg University Dongsan Medical Center, Jung-gu,

Korea University Guro Hospital, Seoul

St. Mercy's Hospital, Bupyoung-dong, Bupyoung-gu

Inha University Hospital, Sinhung-dong, Jung-gu

Wonkwang University Hospital, Iksan

Chonbuk National University Hospital, Jeonju

Seoul National University Hospital, Seoul

National Cancer Center, Ilsan-gu

St. Holly Family Mary's Hospital, Pucheon

Pochon CHA University Hospital, Seongnam-gu

Gil Medical Center, Incheon

Nowon Eulji Hospital, Hagyeil-tong

Korea University Anam Hospital, Anam-dong, Sungbuk-ku

Kangnam Sacred Heart Hospital, Daelim-dong, Yongdeungpo-gu

Yongdong Severance Hospital, Dogok-dong, Kangnam-gu

Korea Cancer Center Hospital, Gongneung-dong, Nowon-gu

Samsung Medical Center, Ilwon-dong, Songpa-gu

Seoul Paik Hospital, Jeo-dong

Ehwa Womans University Mokdong Hospital, Mok-dong, Yangcheon-gu

Seoul Asan Medical Center, Pungnap-dong, Kangnam-gu

Kangbuk Samsung Hospital, Pyoung-dong, Chongro-gu,

Severance Hospital, Shinchon- Dong, Seodaemun-gu

St. Vincent's Hospital, Ji-dong,, Paldal-gu

St. Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT00362674 - Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial | Biotech Hunter | Biotech Hunter